Harrow, Inc. Value of Shares Repurchased and Retired
Harrow, Inc. (HROW) reported Value of Shares Repurchased and Retired of $191 for the 2-month period ending 2013-03-31, per its 10-K filed 2015-03-12.
Discontinued › Shareholders' Equity
us-gaap:StockRepurchasedAndRetiredDuringPeriodValue · last filed 2015-03-12
- 2013-03-31: Stock Repurchased and Retired During Period, Value 2 month $191.00.
| Period end | Stock Repurchased and Retired During Period, Value 2 month |
|---|---|
| 2013-03-31 | $191.00 10-K · filed 2015-03-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Damora Therapeutics, Inc. (DMRA) | $1.250B | -6.10 | |
| OPKO HEALTH, INC. (OPK) | United States | $1.220B | -15.59 |
| LB PHARMACEUTICALS INC (LBRX) | United States | $1.220B | -10.87 |
| Avalyn Pharma Inc. (AVLN) | United States | $1.267B | |
| First Tracks Biotherapeutics, Inc. (TRAX) | United States | $1.280B | |
| Jaguar Health, Inc. (JAGX) | United States | $1.184B | |
| Latigo Biotherapeutics, Inc. (LTGO) | United States | $1.176B | |
| Bicara Therapeutics Inc. (BCAX) | United States | $1.309B | -10.55 |
| Tyra Biosciences, Inc. (TYRA) | United States | $1.337B | -12.83 |
| Kardigan, Inc. (KARD) | United States | $1.346B |